Syros Pharmaceuticals, Inc. (SYRS)
USD 0.21
(-0.1%)
USD 0.21
(-0.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -109.77 Million | -123.06 Million | -99.54 Million | -57.36 Million | -60.25 Million | -40.31 Million |
| Net Income | -164.57 Million | -94.65 Million | -86.55 Million | -84.03 Million | -75.43 Million | -62.27 Million |
| Depreciation & Amortization | 2.25 Million | 2.96 Million | 3.01 Million | 3.03 Million | 2.72 Million | 1.6 Million |
| Deferred income taxes | -5.13 Million | - | -16.45 Million | 326 Thousand | -1.13 Million | - |
| Stock-based compensation | 10.43 Million | 11.41 Million | 10.35 Million | 10.93 Million | 9.83 Million | 6.61 Million |
| Change in working capital | 5.05 Million | -5.51 Million | -10.6 Million | 10.05 Million | -3.48 Million | 14.39 Million |
| Other non-cash items | 42.19 Million | -37.27 Million | 706 Thousand | 2.32 Million | 7.23 Million | -642 Thousand |
| Investing Cash Flow | 37.33 Million | 67.18 Million | -52.65 Million | 46.66 Million | -11.73 Million | -10.64 Million |
| Investments in PPE | -272 Thousand | -1.24 Million | -1.24 Million | -3.33 Million | -12.63 Million | -1.38 Million |
| Acquisitions | 1.56 Million | - | - | - | 110 Thousand | 9000.00 |
| Investment purchases | -50.96 Million | - | -51.4 Million | - | -108.2 Million | -96.76 Million |
| Sales/Maturities of investments | 87.01 Million | 68.42 Million | - | 50 Million | 109 Million | 87.5 Million |
| Other Investing Activities | 37.6 Million | 68.42 Million | -51.4 Million | 50 Million | 904 Thousand | 9000.00 |
| Financing Cash Flow | 43.46 Million | 131.04 Million | 70.51 Million | 142.95 Million | 65.99 Million | 69.08 Million |
| Debt repayment | -65 Thousand | -291 Thousand | -265 Thousand | -39.37 Million | -205 Thousand | -50 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 257 Thousand | 217 Thousand | - | 433 Thousand | 161 Thousand | - |
| Common Stock Issuance | 43.52 Million | 119.76 Million | 70.77 Million | 103.78 Million | 61.18 Million | 69.13 Million |
| Other Financing Activities | 43.52 Million | 11.35 Million | 70.77 Million | 103.57 Million | 5.01 Million | 69.13 Million |
| Accounts receivables | 1.69 Million | 1.28 Million | 7000.00 | 19.99 Million | -20.15 Million | - |
| Accounts payables | 5.13 Million | 2.76 Million | 48 Thousand | -1.05 Million | 1.49 Million | 888 Thousand |
| Inventory | - | -1.28 Million | 1.98 Million | -2.53 Million | -4.35 Million | - |
| Other working capital | -1.77 Million | -8.28 Million | -12.64 Million | -6.35 Million | 19.54 Million | 13.5 Million |
| Cash at beginning of period | 167.46 Million | 95.38 Million | 177.07 Million | 44.81 Million | 50.81 Million | 32.68 Million |
| Cash at end of period | 139.52 Million | 170.55 Million | 95.38 Million | 177.07 Million | 44.81 Million | 50.81 Million |
| Capital Expenditure | -272 Thousand | -1.24 Million | -1.24 Million | -3.33 Million | -12.63 Million | -1.38 Million |
| Effect of forex changes on cash | 967 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -27.94 Million | 75.16 Million | -81.68 Million | 132.25 Million | -5.99 Million | 18.12 Million |
| Free Cash Flow | -110.04 Million | -124.3 Million | -100.78 Million | -60.7 Million | -72.89 Million | -41.69 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.39 Million | -23.32 Million | -3.7 Million | -164.57 Million | -64.38 Million | -40.14 Million |
| Depreciation & Amortization | 23 Thousand | 331 Thousand | 334 Thousand | 2.25 Million | 279 Thousand | 612 Thousand |
| Deferred income taxes | - | - | - | -5.13 Million | 8.07 Million | 6.06 Million |
| Stock-based compensation | 1.62 Million | 1.8 Million | 2.1 Million | 10.43 Million | 1.72 Million | 3.25 Million |
| Change in working capital | 6.78 Million | -3.92 Million | -2.86 Million | 5.05 Million | 6.25 Million | -1.79 Million |
| Other non-cash items | -22.72 Million | 1.79 Million | -23.99 Million | 42.19 Million | 29.48 Million | 147 Thousand |
| Investing Cash Flow | -125 Thousand | 25.06 Million | -24.64 Million | 37.33 Million | 1.52 Million | 28.64 Million |
| Investments in PPE | - | - | - | -272 Thousand | -38 Thousand | - |
| Acquisitions | -125 Thousand | 96 Thousand | 29 Thousand | 1.56 Million | 1.56 Million | - |
| Investment purchases | - | -5.92 Million | -24.66 Million | -50.96 Million | - | - |
| Sales/Maturities of investments | - | 30.89 Million | - | 87.01 Million | - | 28.64 Million |
| Other Investing Activities | - | 25.06 Million | 29 Thousand | 37.6 Million | 1.56 Million | 28.64 Million |
| Financing Cash Flow | - | 41 Thousand | -265 Thousand | 43.46 Million | 43.38 Million | -5000.00 |
| Debt repayment | -265 Thousand | - | -265 Thousand | -65 Thousand | -3000.00 | -5000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 115 Thousand | - | - | 257 Thousand | 257 Thousand | - |
| Common Stock Issuance | -115 Thousand | 115 Thousand | - | 43.52 Million | 43.38 Million | - |
| Other Financing Activities | - | -74 Thousand | -265 Thousand | 43.52 Million | 43.38 Million | -5000.00 |
| Accounts receivables | - | - | - | 1.69 Million | 1.66 Million | 91 Thousand |
| Accounts payables | 2.17 Million | -3.87 Million | -198 Thousand | 5.13 Million | 8.68 Million | -3.83 Million |
| Inventory | - | - | - | - | 29 Thousand | -91 Thousand |
| Other working capital | 2.71 Million | -46 Thousand | -2.66 Million | -1.77 Million | -4.09 Million | 2.04 Million |
| Cash at beginning of period | 78.96 Million | 83.52 Million | 139.52 Million | 167.46 Million | 112.21 Million | 118.52 Million |
| Cash at end of period | 60.39 Million | 78.96 Million | 83.52 Million | 139.52 Million | 139.52 Million | 115.3 Million |
| Capital Expenditure | - | - | - | -272 Thousand | -38 Thousand | - |
| Effect of forex changes on cash | - | - | - | 967 Thousand | 967 Thousand | 10.08 Million |
| Net cash flow / Change in cash | -18.57 Million | -4.55 Million | -56 Million | -27.94 Million | 27.3 Million | -3.22 Million |
| Free Cash Flow | -20.68 Million | -29.66 Million | -31.09 Million | -110.04 Million | -18.6 Million | -31.85 Million |
ALATI
FFMR
600469
6692
ALBHF
HPP